Monotherapy Invest Information

Pharmaceuticals
Positive Topline Results for Novartis' Leqvio® in Lowering LDL-C in Low-to-Moderate ASCVD Risk Patients Aug 28, 2024
Companies
Xilio Therapeutics Commences Phase 1 Trial for XTX101 in Combination Therapy for MSS CRC Dec 7, 2023